Stockhub

Dimerix Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

2 September 2022

  • curprev 14:5114:51, 2 September 2022‎ 94.119.64.3 talk‎ 551 bytes +551‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fi..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Dimerix_Limited’